IgAN中肾脏免疫沉积物与尿补体活化片段的临床价值
本研究基于CureGN队列247例IgA肾病患者的回顾性分析,评估免疫荧光和电镜下的免疫沉积物及入组时尿sC5b9与临床指标的关系。发现在115例活检后6个月内入组的患者中,蛋白尿和尿sC5b9与IgA及C3毛细血管沉积、电镜下的内皮下沉积数量相关;蛋白尿和尿sC5b9各自独立与复合结局相关,且两者均升高时存在交互作用。结论认为免疫沉积物的量和定位与增殖性病变及尿sC5b9相关,尿膜攻击复合物独立与eGFR下降相关。
要点
- 系膜和内皮细胞增生及新月体与IgA和C3毛细血管定位相关。
- 蛋白尿和尿sC5b9与IgA和C3毛细血管沉积及内皮下沉积数量相关。
- 蛋白尿和尿sC5b9独立与肾脏复合结局相关,两者均高时存在交互作用。
核心结论
- 在IgA肾病中,免疫沉积物的量和定位与增殖性病变及尿sC5b9相关。
- 尿膜攻击复合物独立与eGFR下降相关。
研究设计与样本
- 回顾性分析CureGN队列中247例有病理评估和临床随访的IgA肾病患者。
- 评估免疫荧光下IgA、C3、IgG、IgM的强度和定位,电镜下沉积物数量和定位及足突消失,以及入组时尿sC5b9。
主要发现
- 系膜和内皮细胞增生及新月体与免疫荧光下IgA和C3毛细血管定位相关。
- 系膜和内皮细胞增生也与免疫荧光下IgA和C3染色强度及电镜下免疫沉积物强度和足突消失程度相关。
- 在115例活检后6个月内入组的患者中,蛋白尿和尿sC5b9与免疫荧光下IgA和C3毛细血管沉积及电镜下内皮下沉积数量相关。
- 蛋白尿和尿sC5b9各自独立与肾脏失败或eGFR下降≥40%的复合结局相关,两者均升高时存在交互作用。
临床怎么用
- 检测尿sC5b9可能有助于评估IgA肾病进展风险,尤其当蛋白尿升高时。
- 免疫荧光下IgA和C3毛细血管沉积及电镜下内皮下沉积数量或可提示增殖性病变。
局限性
- 回顾性分析设计。
- 部分分析仅基于115例活检后6个月内入组的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Ig deposits and complement activation are central in the pathogenesis of IgA nephropathy (IgAN). Whether immunodeposits, assessed by immunofluorescence (IF) and electron microscopy (EM), or the measurement of urinary complement activation fragments, can help determine the likelihood of progression of IgAN is unknown. METHODS: In this retrospective analysis of 247 patients of IgAN with pathology assessments and clinical follow-up from the Cure Glomerulonephropathy (CureGN) cohort, we assessed immunodeposits by IF (intensity and localization of IgA, C3, IgG, and IgM) and EM (quantity and localization of deposits and foot process effacement [FPE]), as well as urinary membrane attack complex at enrollment (soluble C5b9 [sC5b9]). We tested associations between immunodeposits and urinary sC5b9 with light microscopy (LM) with proteinuria and survival from kidney failure or a ≥ 40% decline in estimated glomerular filtration rate (eGFR; combined outcome). RESULTS: Mesangial and endocapillary hypercellularity and crescents were associated with IgA and C3 capillary localization by IF. Mesangial and endocapillary hypercellularity also correlated with IgA and C3 staining intensity by IF, and immunodeposits intensity and degree of FPE by EM. In 115 incident subjects enrolled within 6 months of their kidney biopsy, proteinuria and urinary sC5b9 were associated with IgA and C3 capillary deposition by IF, as well as the quantity of subendothelial deposits by EM. Finally, proteinuria and urinary sC5b9 were each independently associated with a combined outcome and showed an interaction when both were elevated. CONCLUSION: In IgAN, the amount and localization of immunodeposits correlated with proliferative lesions and urinary sC5b9. In turn, the urinary membrane attack complex was independently associated with loss of eGFR.
引用
- Royal V, Caliskan Y, Laurin LP, et al. Clinical Value of Kidney Immunodeposits and Urinary Complement Activation Fragments in IgAN. Kidney Int Rep. 2026. PMID: 42519591. doi:10.1016/j.ekir.2026.106648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。